JENNIFER WOODY: Open Payments
NPI 1598462012 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $798 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 7 | $116 |
| Novo Nordisk Inc | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| PFIZER INC. | 2 | $48 |
| Lilly USA, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Boston Scientific Corporation | 1 | $33 |
| Amgen Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $22 |
Products named: NEXLETOL, Wegovy, JARDIANCE, VERQUVO, ELIQUIS, ZEPBOUND, FARXIGA, WATCHMAN.
Industry payments across NC — which companies pay providers there.
